cilengitide has been researched along with Bone Cancer in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 6 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fujita, N; Takagi, S | 1 |
| Bianconi, D; Chillà, A; Dorda, A; Geetha, N; Poettler, M; Prager, GW; Redlich, K; Sykoutri, D; Unseld, M; Zielinski, CC | 1 |
| Bode-Lesniewska, B; Born, W; Boro, A; Fuchs, B; Gvozdenovic, A; Meier, D; Muff, R | 1 |
| Bäuerle, T; Berger, MR; Goodman, SL; Komljenovic, D; Merz, M; Semmler, W | 1 |
| Bäuerle, T; Berger, MR; Bretschi, M; Komljenovic, D; Merz, M; Semmler, W | 1 |
| Bäuerle, T; Bretschi, M; Cheng, C; Dimitrakopoulou-Strauss, A; Semmler, W; Strauss, LG; Witt, H | 1 |
6 other study(ies) available for cilengitide and Bone Cancer
| Article | Year |
|---|---|
[Cancer metastasis-related molecules and their targeted drugs].
Topics: Animals; Antibodies, Monoclonal, Humanized; Bone Neoplasms; Denosumab; Humans; Integrins; Membrane Glycoproteins; Membrane Proteins; Molecular Targeted Therapy; Neoplasm Metastasis; Snake Venoms | 2012 |
Effects of cilengitide in osteoclast maturation and behavior.
Topics: Animals; Antineoplastic Agents; Bone Neoplasms; Breast Neoplasms; Cell Adhesion; Cell Line, Tumor; Cell Movement; Drug Screening Assays, Antitumor; Female; Humans; Integrin alpha Chains; Mice; Osteoclasts; Signal Transduction; Snake Venoms | 2015 |
Targeting αvβ3 and αvβ5 integrins inhibits pulmonary metastasis in an intratibial xenograft osteosarcoma mouse model.
Topics: Animals; Bone Neoplasms; Cell Line, Tumor; G1 Phase Cell Cycle Checkpoints; Hippo Signaling Pathway; Humans; Integrin alphaVbeta3; Lung Neoplasms; Mice; Osteosarcoma; Protein Serine-Threonine Kinases; Receptors, Vitronectin; Signal Transduction; Snake Venoms; Tibia; Xenograft Model Antitumor Assays | 2016 |
Cilengitide inhibits progression of experimental breast cancer bone metastases as imaged noninvasively using VCT, MRI and DCE-MRI in a longitudinal in vivo study.
Topics: Animals; Bone Neoplasms; Breast Neoplasms; Cell Line, Tumor; Disease Progression; Female; Humans; Integrin alphaVbeta3; Magnetic Resonance Imaging; Mammary Neoplasms, Experimental; Rats; Rats, Nude; Receptors, Vitronectin; Snake Venoms; Tomography, X-Ray Computed | 2011 |
Cilengitide inhibits metastatic bone colonization in a nude rat model.
Topics: Animals; Bone Neoplasms; Bone Resorption; Breast Neoplasms; Cell Growth Processes; Cell Line, Tumor; Cell Movement; Disease Models, Animal; Female; Humans; Magnetic Resonance Imaging; Neoplasm Invasiveness; Osteoclasts; Rats; Rats, Nude; Snake Venoms; Xenograft Model Antitumor Assays | 2011 |
Cilengitide affects tumor compartment, vascularization and microenvironment in experimental bone metastases as shown by longitudinal ¹⁸F-FDG PET and gene expression analysis.
Topics: Animals; Biomarkers, Tumor; Bone Neoplasms; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Gene Expression Profiling; Humans; Integrin alphaVbeta3; Longitudinal Studies; Male; Neovascularization, Pathologic; Oligonucleotide Array Sequence Analysis; Positron-Emission Tomography; Radiopharmaceuticals; Rats; Rats, Nude; Real-Time Polymerase Chain Reaction; Receptors, Vitronectin; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Snake Venoms; Tumor Cells, Cultured; Tumor Microenvironment | 2013 |